Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px
Document › Details

Roche. (6/3/17). "Press Release: Roche Presents New Data for Tecentriq (atezolizumab) and Updates from Across Its Cancer Immunotherapy Development Programme at ASCO 2017". Basel.

Region Region Chicago, IL
  Country United States (USA)
Organisations Organisation Roche (Group)
  Organisation 2 American Society of Clinical Oncology (ASCO)
Products Product Tecentriq®
  Product 2 ASCO 2017 Annual Meeting Chicago
Person Person Horning, Sandra (Roche 201401–201912 CMO + Head Global Product Development joined 2009 RETIRED 12/19)
     


   
Record changed: 2023-06-05

Advertisement

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for Roche (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x300px




» top